Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q24531989)
Watch
English
Rasburicase (Elitek): a novel agent for tumor lysis syndrome
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
16200184
retrieved
4 July 2017
title
Rasburicase (Elitek): a novel agent for tumor lysis syndrome
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16200184
retrieved
4 July 2017
main subject
tumor lysis syndrome
1 reference
based on heuristic
inferred from title
author name string
Sis Ueng
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
16200184
retrieved
4 July 2017
language of work or name
English
0 references
publication date
1 July 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
16200184
retrieved
4 July 2017
published in
Baylor University Medical Center Proceedings
1 reference
stated in
Europe PubMed Central
PubMed ID
16200184
retrieved
4 July 2017
volume
18
1 reference
stated in
Europe PubMed Central
PubMed ID
16200184
retrieved
4 July 2017
issue
3
1 reference
stated in
Europe PubMed Central
PubMed ID
16200184
retrieved
4 July 2017
page(s)
275-279
1 reference
stated in
Europe PubMed Central
PubMed ID
16200184
retrieved
4 July 2017
cites work
Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte [...]
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1200736
retrieved
27 September 2017
Rasburicase for the treatment and prevention of hyperuricemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1200736
retrieved
27 September 2017
Recombinant urate oxidase for prevention of hyperuricemia and tumor lysis syndrome in lymphoid malignancies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1200736
retrieved
27 September 2017
Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1200736
retrieved
27 September 2017
Prevention and treatment of hyperuricemia in hematological malignancies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1200736
retrieved
27 September 2017
Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1200736
retrieved
27 September 2017
Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1200736
retrieved
29 November 2018
Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1200736
retrieved
29 November 2018
A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1200736
retrieved
29 November 2018
Identifiers
DOI
10.1080/08998280.2005.11928082
0 references
PMCID
1200736
1 reference
stated in
Europe PubMed Central
PubMed ID
16200184
retrieved
4 July 2017
PubMed ID
16200184
1 reference
stated in
Europe PubMed Central
PubMed ID
16200184
retrieved
4 July 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
